Page 2 - Thomas Theuringer News Today

Simplified and accelerated research workflow including high-quality DNA extraction kits, library preparation for whole genome metagenomics, and user-friendly bioinformatics analysis // Workflow enables diverse microbiome research applications, including gut health, soil microbiology, and antibiotic resistance, maximizing DNA diversity and minimizing bias // Expanding growing portfolio of QIAGEN microbiome solutions, covering every aspect of the scientific workflowVenlo, the Netherlands, Nov. 06,

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Venlo, the Netherlands, Oct. 30, 2023 -- QIAGEN announced results for the third quarter and first nine months of 2023. Net sales results of $470 million at constant exchange rates for Q3 2023...

Q3 2023: Net sales of $476 million (-5% at actual rates, -6% at constant exchange rates, CER); diluted EPS of $0.34 and adjusted diluted EPS of $0.50 // Net sales at CER of $470 million ahead of outlook for at least $465 million CER and adjusted diluted EPS of $0.50 CER ahead of outlook for at least $0.48 CER // 5% CER sales growth in non-COVID portfolio to $442 million, supported by higher sales from instruments as well as recurring consumables and related revenues // 9M 2023: 8% CER sales grow

Venlo, the Netherlands, Oct. 04, 2023 -- QIAGEN today announced the launch of its QuantiFERON-EBV RUO assay. Epstein-Barr virus , or human herpes virus 4, is estimated in various epidemiological...

Venlo, the Netherlands, and Redwood City, California, Sept. 28, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)) announced today the expansion of its clinical decision support software,

Venlo, the Netherlands, Sept. 27, 2023 -- QIAGEN today announced the release of its Sustainability Report 2022, emphasizing its unwavering focus on driving positive change for society through its...

Venlo, the Netherlands, Sept. 25, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced the extension of its eco-friendlier QIAwave product line with the addition of two new

QIAGEN N.V. By: /s/ Roland... -Today at 06:08 am- MarketScreener

Venlo, the Netherlands, July 18, 2023 -- QIAGEN announced today the expansion of its digital PCR offering for the development of cell and gene therapies in the biopharma industry. The company...